Literature DB >> 27510548

Diabetes: PCSK9 inhibition is not associated with new-onset diabetes.

Irene Fernández-Ruiz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27510548     DOI： 10.1038/nrcardio.2016.132

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies.

Authors:  Helen M Colhoun; Henry N Ginsberg; Jennifer G Robinson; Lawrence A Leiter; Dirk Müller-Wieland; Robert R Henry; Bertrand Cariou; Marie T Baccara-Dinet; Robert Pordy; Laurence Merlet; Robert H Eckel
Journal:  Eur Heart J       Date:  2016-07-26       Impact factor: 29.983
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.